Treatment of inflammatory diseases of the nose

J. Mullol, C. Picado

Source: Eur Respir Mon; 2001: 18: 165–183
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Mullol, C. Picado. Treatment of inflammatory diseases of the nose. Eur Respir Mon; 2001: 18: 165–183

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Nonallergic rhinitis, sinonasal polyposis and asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 108s
Year: 2003

Rhinitis, nasosinusal polyposis and asthma: clinical aspects
Source: ISSN=1025-448x, ISBN=1-904097-19-17, page=101
Year: 2001

Nasal polyposis, analgesics intolerance and asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 428s
Year: 2001

Treatment of nasal polyposis in aspirine sensitive asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 425s
Year: 2001

Type 2 inflammation-related comorbidities among patients with asthma, chronic rhinosinusitis with nasal polyps, and atopic dermatitis
Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Year: 2020

Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020

Aspirin-induced urticaria/angioedema without respiratory symptoms in severe asthmatics with nasal polyposis
Source: Eur Respir J 2002; 20: Suppl. 38, 512s
Year: 2002

Rhinitis, nasal polyposis and asthma: pathological aspects
Source: ISSN=1025-448x, ISBN=1-904097-19-18, page=115
Year: 2001

The upper airways in severe asthma
Source: Eur Respir Mon 2011; 51: 189-199
Year: 2011

Mepolizumab in the treatment of severe asthma with nasal polyposis: real-life study
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021

Low-dose inhaled and nasal corticosteroid use and the risk of cataracts
Source: Eur Respir J 2006; 27: 1168-1174
Year: 2006

To assess the effects of combined nasal and inhaled corticosteroid in patients with asthma and persistent allergic rhinitis
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

The nose–lung interaction in allergic rhinitis and asthma: united airways disease
Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside
Year: 2007

QAV680, cetirizine and their combination reduce nasal symptoms in patients with intermittent allergic rhinitis in an environmental exposure chamber
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014

Budesonide nasal spray alone or in combination with cetirizine in patients with severe seasonal allergic rhinitis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 45s
Year: 2002

Pathophysiology of airway hyperresponsiveness in patients with nasal polyposis
Source: Annual Congress 2011 - Phenotyping airway diseases
Year: 2011

Intranasal and inhaled corticosteroids in allergic rhinitis and asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004

Early treatment of perennial rhinitis with budesonide or cetirizine: effect on nasal inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 92s
Year: 2002

Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function
Source: Eur Respir J 2008; 32: 989-996
Year: 2008

Allergic inflammation of the upper and lower airways: a continuum of disease?
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=211
Year: 2003